Suboxone Film Manufacturers Agree That MDL Coordination Is Needed

(December 14, 2023, 7:40 AM EST) -- WASHINGTON, D.C. — The manufacturer of Suboxone film facing allegations that the prescription drug used to treats opioid use disorder caused extensive dental decay agreed in responses to a motion for transfer that the U.S. Judicial Panel on Multidistrict Litigation should consolidate the cases for pretrial purposes....